Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$11.35 - $12.32 $1.2 Million - $1.3 Million
105,300 Added 5.95%
1,873,694 $23 Million
Q4 2022

Feb 14, 2023

BUY
$3.68 - $12.51 $4,784 - $16,263
1,300 Added 0.07%
1,768,394 $20.3 Million
Q3 2022

Nov 14, 2022

BUY
$3.7 - $6.06 $33,629 - $55,079
9,089 Added 0.52%
1,767,094 $6.63 Million
Q2 2022

Aug 15, 2022

BUY
$4.89 - $7.13 $217,081 - $316,522
44,393 Added 2.59%
1,758,005 $10.5 Million
Q1 2022

May 16, 2022

BUY
$3.75 - $6.82 $617,733 - $1.12 Million
164,729 Added 10.64%
1,713,612 $10.8 Million
Q4 2020

Feb 16, 2021

BUY
$3.69 - $8.31 $931,529 - $2.1 Million
252,447 Added 19.47%
1,548,883 $10.7 Million
Q3 2020

Nov 16, 2020

BUY
$3.1 - $4.3 $300,173 - $416,369
96,830 Added 8.07%
1,296,436 $5.19 Million
Q2 2020

Aug 14, 2020

BUY
$2.21 - $3.88 $58,432 - $102,587
26,440 Added 2.25%
1,199,606 $4 Million
Q3 2019

Nov 14, 2019

SELL
$4.16 - $6.05 $162,148 - $235,816
-38,978 Reduced 3.22%
1,173,166 $5.27 Million
Q2 2019

Aug 14, 2019

BUY
$4.39 - $5.66 $296,592 - $382,395
67,561 Added 5.9%
1,212,144 $7.33 Million
Q1 2019

May 15, 2019

BUY
$3.19 - $5.73 $816,521 - $1.47 Million
255,963 Added 28.8%
1,144,583 $7.96 Million
Q4 2018

Feb 14, 2019

BUY
$2.95 - $4.15 $630,179 - $886,523
213,620 Added 31.65%
888,620 $3.43 Million
Q3 2018

Nov 14, 2018

BUY
$3.91 - $4.66 $163,058 - $194,335
41,703 Added 6.59%
675,000 $3.6 Million
Q2 2018

Aug 14, 2018

BUY
$3.86 - $7.61 $1.9 Million - $3.75 Million
492,440 Added 349.6%
633,297 $3.11 Million
Q1 2018

May 15, 2018

SELL
$6.24 - $9.15 $1.38 Million - $2.03 Million
-221,478 Reduced 61.13%
140,857 $1.13 Million
Q4 2017

Feb 14, 2018

SELL
$7.99 - $11.87 $221,043 - $328,383
-27,665 Reduced 7.09%
362,335 $3.71 Million
Q3 2017

Nov 14, 2017

BUY
$9.13 - $11.72 $3.56 Million - $4.57 Million
390,000
390,000 $5.67 Million

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Newtyn Management, LLC Portfolio

Follow Newtyn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.